Cancer Therapy Market is estimated to be US$ 360.9 billion by 2030 with a CAGR of 8.9% during the forecast period
Cancer Therapy Market, By Cancer Type (Breast Cancer, Prostate Cancer, Blood Cancer,
Gastrointestinal Cancer, Respiratory/Lung Cancer, Gynecologic Cancer, and Other
Cancer Types), By Treatment Type (Immunotherapy, Hormonal Therapy,
Chemotherapy, Targeted Therapy, and Other Treatment Types), By End User (Cancer
and Radiation Therapy Centers, Hospitals, and Specialty Clinics), and
Region - Global Forecast to 2030" global cancer
therapy market is projected to grow from US$ 66.5 billion in 2019 Certain
factors that are driving the market growth include increasing Patient
Assistance Programs (PAPs), increasing government initiatives for cancer
awareness, rising prevalence of cancer worldwide, and strong R&D
initiatives from key players. The upsurge in demand for personalized
medicine and high potential of developing nations is expected to provide new
opportunities for the market players in future.
Key Highlights:
·In January 2020, Medtronic Launches Efficio software to help
clinicians efficiently manage targeted drug delivery therapy with SynchroMed
·In January 2020, Roche announced the completion of a
supplemental Biologics License Application (sBLA) submission to the US Food and
Drug Administration (FDA) for Tecentriq® (atezolizumab) in
combination with Avastin® (bevacizumab), for the treatment of
people with unresectable hepatocellular carcinoma (HCC) who have not received
prior systemic therapy.
Key Market Insights from the
report:
The global cancer therapy market accounted for
US$ 66.5 billion in 2019 and is projected to register a moderate CAGR of 8.50%
over the forecast period. The market report has been segmented on the cancer
type, treatment type, end user, and region.
·By cancer type, breast cancer is expected to dominate in this segment, due to higher and continuously
increasing prevalence
of breast cancer across the world.
·By treatment type, the target therapy segment is dominating in this segment, due to its specificit
toward cancer cells, while
sparing the toxicity to off-target cells.
·By end user, the global cancer therapy market is sub-divided into cancer and radiation therapy
centers, hospitals, and specialty clinics.
·By region, North America is projected to lead the global cancer therapy market and is expected to
remain dominant during the forecast period, owing to the increased adoption of cancer
therapy.
Before purchasing
this report, request a sample or make an inquiry by clicking the following
link:
https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/3768
The prominent player operating in the global
cancer therapy market includes Medtronic Inc., F. Hoffman-La Roche Ltd.,
Universal Cancer Therapy Inc., LifeScan Inc., Abbott Point of Care Inc., Sysmex
Corporation, Pharmaco-Kinesis Corporation (PKC), Bio-Rad laboratories Inc.,
Cancer Therapy International Pte. Ltd., ACON Laboratories, Inc., Nova
Biomedical Corp.
About Prophecy Market Insights
Prophecy Market Insights is specialized market research,
analytics, marketing/business strategy, and solutions that offers strategic and
tactical support to clients for making well-informed business decisions and to
identify and achieve high-value opportunities in the target business area. We
also help our clients to address business challenges and provide the best
possible solutions to overcome them and transform their business.
To know more
Contact Us:
Sales
Prophecy Market Insights
Email- sales@prophecymarketinsights.com
Website- www.prophecymarketinsights.com

Comments
Post a Comment